发明名称 |
Anti-ANGPTL3 Antibodies and Uses Thereof |
摘要 |
A fully human antibody or antigen-binding fragment of a human antibody that specifically binds and inhibits or interferes with at least one activity of human angiopoietin-like protein 3 (hANGPTL3) is provided. The human anti-hANGPTL3 antibodies are useful in treating diseases or disorders associated with ANGPTL3, such as hyperlipidemia, hyperlipoproteinemia and dyslipidemia, including hypertriglyceridemia, hypercholesterolemia, chylomicronemia, and so forth. Furthermore, the anti-hANGPTL3 antibodies can be administered to a subject in need thereof to prevent or treat diseases or disorders, for which abnormal lipid metabolism is a risk factor. Such diseases or disorders include cardiovascular diseases, such as atherosclerosis and coronary artery diseases; acute pancreatitis; nonalcoholic steatohepatitis (NASH); diabetes; obesity; and the like. |
申请公布号 |
US2015197564(A1) |
申请公布日期 |
2015.07.16 |
申请号 |
US201514667121 |
申请日期 |
2015.03.24 |
申请人 |
Regeneron Pharmaceuticals, Inc. |
发明人 |
Sleeman Mark W.;Gusarova Viktoria;Murphy Andrew J. |
分类号 |
C07K16/22;A61K45/06;A61K39/395 |
主分类号 |
C07K16/22 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for preventing or treating a disease or disorder which is prevented, ameliorated, improved or inhibited by reduction or inhibition of ANGPTL3 activity, the method comprising administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising an isolated human antibody or antigen-binding fragment thereof that specifically binds human angiopoietin-like protein 3 (hANGPTL3) of SEQ ID NO:161 and neutralizes, reduces, or interferes with at least one activity of hANGPTL3, and a pharmaceutically acceptable carrier. |
地址 |
Tarrytown NY US |